Antitubercular drugs: new drugs designed by molecular modifications

Tuberculosis is a long-term infection caused by the bacteria Mycobacterium tuberculosis. Long-term TB treatment has several drawbacks, including medication resistance, noncompliance with therapy, and a scarcity of therapeutic options. It is critical to find new medications that are both safer and more effective. Molecular modification is a valuable method for identifying novel chemicals that can overcome these obstacles. The primary tactics to obtain a novel anti-tubercular medication are summarized in this paper.